Skip to main content
. 2015 Mar 31;10(3):e0122374. doi: 10.1371/journal.pone.0122374

Table 1. Stimulation (in fold change) of cytokines and chemokines in DCs-treated with Cp, Am, [Am+Cp] or LPS groups compared to control group.

Cytokines/Chemokines Alternate Nomenclature Cp Am [Am+Cp] LPS
IL-6 10.23 14.18 12.12 9.95
CSF3 G-CSF 7.37 6.82 10.60 15.58
CCL3 MIP-1α 11.15 4.96 9.16 10.74
CCL1 I-309/TAC-3 6.61 5.93 7.11 9.03
TNF-α 4.62 4.32 6.99 5.16
IL-1β IL-1F2 6.36 5.89 5.38 9.86
IL-1α IL-1F1 3.75 3.27 4.95 6.08
CXCL10 IP-10/CRG-2 4.85 6.82 4.80 5.59
CXCL2 MIP-2 3.62 5.81 3.62 3.31
CCL2 MCP-1 1.80 2.08 3.31 2.71
CXCL9 MIG 3.24 2.90 3.12 4.13
CXCL1 KC 1.72 2.37 3.12 2.38
IL-5 2.42 3.92 3.11 2.29
CCL4 MIP-1β 6.15 2.66 2.68 18.41
IL-7 1.85 3.05 2.64 1.89
CSF2 GM-CSF 2.51 4.31 2.49 2.27
CSF1 M-CSF 1.46 1.93 2.35 1.57
TREM-1 1.24 1.43 2.17 1.33
IL-10 2.63 1.96 2.02 2.59
CXCL11 I-TAC 1.76 2.96 1.90 1.93

* Fold change = treatment group/control untreated group

** Control group: DC+TCL